Ajou University repository

Molecular Oncology
ISSN
  • E1878-0261
  • P1574-7891
Publisher

Elsevier BV

Listed on
(Coverage)

JCR2009-2023

SJR2008-2020;2022-2023

CiteScore2011-2023

SCIE2010-2024

SCOPUS2017-2024

MEDLINE2016-2024

DOAJ2018-2024

EMBASE2016-2024

OA Info.
OA oa mark

based on the information

  • 2018;2019;2020;2021;2022;2023;2024;2025;
Keywords cancer, molecular biology, molecular genetics
Review Process Open peer review
Journal info.
pages
Licences CC BY
Copyrights Yes
DOAJ Coverage Added on Date : 2017-10-27T11:00:26Z
Subject(s) Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Active
Active

based on the information

  • SCOPUS:2024-10
Country
USA
Aime & Scopes
Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research. The emphasis is on work that significantly advances our understanding of disease processes leading to human tumour development and/or establishes novel concepts of clear clinical significance in diagnosis, prognosis and prevention strategies for cancer patients. Submissions that meet the high standards of the journal are sent for rigorous, single-blind peer review by experts in the field. Topics include, but are not limited to: /// Key biological processes such as cell cycle; DNA repair; apoptosis; invasion and metastasis; angiogenesis and lymphangiogenesis; cell signalling and interactive networks; immune response. /// Emerging technologies (genomics, proteomics, functional genomics, metabolomics, tissue arrays, imaging), and model systems. /// Biomarkers: diagnosis, prognosis, stratification and efficacy. /// Cancer genetics, epigenetics, and genomic instability. /// Minimal residual disease, pre-malignant lesions. /// Cancer micro-environment. /// Molecular pathology. /// Tumour immunology. /// Translational research. /// Cancer therapy (target discovery, drug design, immunotherapy, combination therapies, resistance, and individualised treatment). /// Chemotherapy, radiotherapy and surgery. /// Clinical pharmacology. /// Clinical trials, integration of basic science into cancer clinical trials. /// Molecular epidemiology.
Article List

Showing results 1 to 1 of 1

A novel anti-c-Kit antibody–drug conjugate to treat wild-type and activating-mutant c-Kit-positive tumorsoa mark
  • Kim, Jin Ock;
  • Kim, Kwang Hyeok;
  • Baek, Eun Ji;
  • Park, Bomi;
  • So, Min Kyung;
  • Ko, Byoung Joon;
  • Ko, Han Jik;
  • Park, Sang Gyu
  • 2022-03-01
  • Molecular Oncology, Vol.16 No.6, pp.1290-1308
  • John Wiley and Sons Ltd
1